Clinical Trial Update: Phase 3 Boosting Study for the SARS-CoV-2 rS Variant Vaccines [Phase 3]

View source ↗

Summary

Phase 3 trial update for SARS-CoV-2 rS variant vaccines completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars Coronavirus 2 Infection

Drugs mentioned

• SARS-CoV-2 rS variant vaccines (Novavax)

Snippet

Sponsor: Novavax | Conditions: COVID-19, SARS CoV 2 Infection | Phase 3 | Status: COMPLETED